AML-MSCs in remission secreted more ALPL compared to D-MSCs (Log2FC = 5.06, p = 0.004) and AML-MSCs at the onset (Log2FC = −1.6, p = 0.02). The gene discussed is ALPL; the disease is acute myeloid leukemia.